PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Tennessee Valley Veteran\'s Affairs Geriatric Research Education Clinical Center (GRECC), Nashville, TN, USA. Electronic address: wes.ely@vumc.org.\', \'Translational Health Sciences, University of Bristol, Bristol, UK; Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol, UK.\', \'Eli Lilly and Company, Indianapolis, IN, USA.\', \'Swedish Center for Research and Innovation, Swedish Medical Center, Providence St Joseph Health, Seattle, WA, USA; Division of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle, WA, USA.\', \'Instituto de Pesquisa Clínica de Campinas (IPECC), Campinas, São Paulo, Brazil.\', \'Emory University School of Medicine, Rollins School of Public Health, Emory Vaccine Center, Atlanta, GA, USA; Atlanta Veterans Affairs Medical Center, Decatur, GA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2600(22)00006-610.1016/S2213-2600(22)00006-6
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 35123660
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35123660>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35123660>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all